Nifty Pharma Share Price
18 Sep, 2026 3:49 PM (IST)
Nifty Pharma Performance
- Today's Low
- ₹26,599
- Today's High
- ₹26,849
- 52 Week Low
- ₹21,150
- 52 Week High
- ₹27,188
- Open Price₹26,614
- Previous Close₹26,579
- Volume31,176,682
- 50 DMA₹26,228.90
- 100 DMA₹25,488.20
- 200 DMA₹24,455.40
Nifty Pharma Chart
Investment Returns
- Over 1 Month + 1.51%
- Over 3 Month + 9.2%
- Over 6 Month + 20.85%
- Over 1 Year + 17.74%
Smart Investing Starts Here Start SIP with Nifty Pharma for Steady Growth!
Nifty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 41.36
- PEG Ratio
- -
- Market Cap Cr
- -
- P/B Ratio
- -
- Average True Range
- 329.9
- EPS
- -
- Dividend Yield
- 0.53
- MACD Signal
- 35
- RSI
- 54.62
- MFI
- -
Nifty Pharma Financials
Nifty Pharma Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹26,553.80
- 50 Day
- ₹26,228.90
- 100 Day
- ₹25,488.20
- 200 Day
- ₹24,455.40
Resistance and Support
- R3 27,090.10
- R2 26,969.50
- R1 26,839.80
- S1 26,589.60
- S2 26,469.00
- S3 26,339.30
About Nifty Pharma
- NSE Symbol
- NIFTYPHARMA
- BSE Symbol
- ISIN
- NIFTYPHARMA
Similar Stocks to Nifty Pharma
Popular Stocks
Nifty Pharma FAQs
Nifty Pharma share price is ₹26,710 As on 20 September, 2026 | 15:06
The P/E ratio of Nifty Pharma is 41.36 As on 20 September, 2026 | 15:06
The PB ratio of Nifty Pharma is 5.02 As on 20 September, 2026 | 15:06
The 52 week High & Low of Nifty Pharma is ₹27188.4/₹21149.9 respectively As on 20 September, 2026 | 15:06
Investors can follow these basic steps:
Step 1: Open a Demat and trading account with a registered intermediary.
Step 2: Search for the required Nifty Pharma stock or eligible pharma ETF.
Step 3: Review the company's financial information, valuation, product details and relevant risks.
Step 4: Place an order after considering the applicable charges and investment requirements.
Investors can also explore eligible pharma-focused mutual funds instead of selecting individual stocks.
Nifty Pharma stocks are the companies that form part of the Nifty Pharma Index. Some of the leading constituents include Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Cipla, Divi's Laboratories and Lupin. Their approximate weights can change following market movements and index rebalancing.
The index itself cannot be traded like an individual share. Investors can access its constituent stocks individually, invest through an eligible pharma ETF such as PHARMABEES, or consider suitable pharma-focused index mutual funds.
The index itself cannot be bought or sold. Individual constituent stocks can be traded according to applicable exchange rules. Eligible ETFs can also be traded on exchange trading days, subject to their market liquidity and applicable conditions.
Nifty Pharma provides focused sector exposure, but regulatory, currency, concentration and market risks remain relevant when assessing any investment linked to the index.
Nifty Pharma represents 20 pharmaceutical companies, while Nifty 50 tracks 50 companies across different sectors. Nifty Pharma therefore provides sector-focused exposure, whereas Nifty 50 provides broader market exposure.
Investors can look for eligible pharma-focused ETFs or index mutual funds that track a relevant pharmaceutical index. Before investing, review the fund's objective, tracking approach, expenses, liquidity, risk factors and applicable terms.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.